Welcome at the Institute of Clinical Neuroimmunology

Our institute is devoted to the diagnosis and treatment of neuroimmunological diseases, that is, autoimmune disorders of the nervous system. In autoimmune diseases, the immune system “erroneously” attacks the body´s own tissues. By far the most frequent of these diseases is multiple sclerosis.

The Institute of Clinical Neuroimmunology was founded in 1999. It is the first university institute in Germany focusing on neuroimmunological diseases. In close association with the Department of Neurology of the LMU, Campus Grosshadern, we are seeing patients with multiple sclerosis, myasthenia gravis, polymyositis, paraneoplastic autoimmune diseases, and other neurological autoimmune diseases in our outpatient clinic (PD. Dr Tania Kuempfel). Inpatients are treated in the Department of Neurology.

Apart from the diagnosis and treatment of neuroimmunological diseases, our main focus is on research into the causes and mechanisms of these disorders. Traditionally we have a close connection with the Department of Neuroimmunology at the Max Planck Institute of Neurobiology in Martinsried, headed by Prof. Dr. Hartmut Wekerle. The spectrum of our research topics ranges from the molecular mechanisms and pathogenesis of neuroimmunological disorders (Max Planck groups of Prof. Dr. Edgar Meinl and PD. Dr. Klaus Dornmair) to development of new neuroprotective and neuroregenerative therapies at the Research Unit Therapy Development (with the groups of Prof. Dr. Martin Kerschensteiner and Dr. Florence Bareyre). Our research is supported by different sources, including the Max Planck Society, the DFG (German Research Council), the BMBF (Federal ministry of education and research), and the European Community.   

Sincerely yours,

Reinhard Hohlfeld

Director of the Institute

member of